Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

309.73 

-2.51 -0.8%

as of May 17 '21

52 Week Range:

171.38 320.39


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Oct '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 11.64
13.02
16.99
19.08
22.15
24.23
28.23
33.14
25.66
1.85
-0.67
growth rate 11.9% 30.5% 12.3% 16.1% 9.4% 16.5% 17.4% -22.6% -92.8% -100.0%
Earnings BIT 437.86
509.25
587.80
599.90
544.08
578.25
628.56
677.97
691.24
716.80
679.61
growth rate 16.3% 15.4% 2.1% -9.3% 6.3% 8.7% 7.9% 2.0% 3.7% -5.2%
Avg.PE 19.16
15.80
16.81
19.23
23.46
22.50
24.17
800.44
300.33
300.33
300.33
growth rate -17.5% 6.4% 14.4% 22.0% -4.1% 7.4% 3,211.7% -62.5% 0.0% 0.0%
ROA 18.03
17.14
15.67
13.33
11.57
11.52
11.68
0.41
13.12
18.85
19.33
growth rate -4.9% -8.6% -14.9% -13.2% -0.4% 1.4% -96.5% 3,100.0% 43.7% 2.6%
ROE 39.81
37.73
34.26
27.86
23.60
23.73
23.92
0.90
31.24
87.67
growth rate -5.2% -9.2% -18.7% -15.3% 0.6% 0.8% -96.2% 3,371.1% 180.6%
ROIC 23.66
22.18
19.91
16.52
14.13
13.86
13.81
0.78
17.34
28.80
33.89
growth rate -6.3% -10.2% -17.0% -14.5% -1.9% -0.4% -94.4% 2,123.1% 66.1% 17.7%
Cur. Ratio 4.11
3.23
4.48
5.24
4.91
5.70
6.99
7.04
5.93
2.22
1.74
growth rate -21.4% 38.7% 17.0% -6.3% 16.1% 22.6% 0.7% -15.8% -62.6% -21.6%
Quick Ratio 3.38
2.74
3.85
4.58
4.28
5.08
6.35
6.48
5.13
1.56
1.26
growth rate -18.9% 40.5% 19.0% -6.6% 18.7% 25.0% 2.1% -20.8% -69.6% -19.2%
Leverage 2.18
2.22
2.16
2.03
2.05
2.07
2.03
2.38
2.38
12.23
growth rate 1.8% -2.7% -6.0% 1.0% 1.0% -1.9% 17.2% 0.0% 126.7%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Oct '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 358.20
367.09
404.60
431.00
433.62
468.32
489.34
533.83
568.32
587.73
573.32
growth rate 2.5% 10.2% 6.5% 0.6% 8.0% 4.5% 9.1% 6.5% 3.4% -2.5%
Acct.Payable 127.97
54.70
65.00
65.70
70.57
67.74
64.54
68.17
49.00
72.21
growth rate -57.3% 18.8% 1.1% 7.4% -4.0% -4.7% 5.6% -28.1% 47.4%
Cur.Assets 1,586.60
1,942.10
2,257.70
2,556.30
2,817.04
3,213.53
3,635.45
4,270.13
2,663.16
1,312.49
1,401.03
growth rate 22.4% 16.3% 13.2% 10.2% 14.1% 13.1% 17.5% -37.6% -50.7% 6.8%
Total Assets 2,327.70
2,723.23
3,168.20
3,582.60
3,874.69
4,268.68
4,662.06
5,324.35
3,727.43
2,557.06
2,839.92
growth rate 17.0% 16.3% 13.1% 8.2% 10.2% 9.2% 14.2% -30.0% -31.4% 11.1%
Cash 308.50
383.99
481.00
440.80
422.18
487.67
505.63
642.32
796.28
335.72
436.70
growth rate 24.5% 25.3% -8.4% -4.2% 15.5% 3.7% 27.0% 24.0% -57.8% 30.1%
Inventory 204.30
212.86
73.30
76.90
246.43
263.42
262.68
270.29
291.57
320.55
304.28
growth rate 4.2% -65.6% 4.9% 220.5% 6.9% -0.3% 2.9% 7.9% 9.9% -5.1%
Cur.Liabilities 385.90
601.86
504.20
487.50
580.49
564.08
520.32
606.16
448.93
591.33
804.98
growth rate 56.0% -16.2% -3.3% 19.1% -2.8% -7.8% 16.5% -25.9% 31.7% 36.1%
Liabilities 1,258.90
1,496.66
1,700.80
1,819.50
1,980.02
2,209.83
2,360.11
3,090.57
2,160.17
2,773.34
2,607.78
growth rate 18.9% 13.6% 7.0% 8.8% 11.6% 6.8% 31.0% -30.1% 28.4% -6.0%
LT Debt 700.00
700.00
1,045.00
1,190.00
1,237.46
1,493.03
1,701.97
1,897.50
1,148.17
1,580.80
1,251.51
growth rate 0.0% 49.3% 13.9% 4.0% 20.7% 14.0% 11.5% -39.5% 37.7% -20.8%
Equity 1,068.80
1,226.58
1,467.40
1,763.20
1,894.67
2,058.85
2,301.95
2,233.79
1,567.26
-216.28
232.14
growth rate 14.8% 19.6% 20.2% 7.5% 8.7% 11.8% -3.0% -29.8% -100.0% 100.0%
Common Shares 94.00
92.00
89.00
87.00
85.00
83.00
81.00
81.00
78.00
68.00
62.00
growth rate -2.1% -3.3% -2.3% -2.3% -2.4% -2.4% 0.0% -3.7% -12.8% -8.8%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Oct '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 62.70
85.44
104.75
118.45
91.12
100.01
94.97
85.47
96.08
163.82
172.38
growth rate 36.3% 22.6% 13.1% -23.1% 9.8% -5.0% -10.0% 12.4% 70.5% 5.2%
Cash Dividends 0.00 0.00 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 457.90
497.37
449.30
484.90
511.65
573.25
642.92
697.64
604.45
643.09
790.51
growth rate 8.6% -9.7% 7.9% 5.5% 12.0% 12.2% 8.5% -13.4% 6.4% 22.9%
FCF per Share 4.20
4.46
3.87
4.01
4.63
5.52
6.20
7.22
6.20
7.36
8.54
growth rate 6.2% -13.2% 3.6% 15.5% 19.2% 12.3% 16.5% -14.1% 18.7% 16.0%
Sale Purchase of Stock -310.68
-295.90
-301.60
73.85
52.06
62.19
97.79
growth rate 0.0% 0.0% 100.0% -29.5% 19.5% 57.2%
FCF 395.00
412.00
345.00
366.00
405.00
457.00
534.00
607.00
508.00
479.00
618.00
growth rate 4.3% -16.3% 6.1% 10.7% 12.8% 16.9% 13.7% -16.3% -5.7% 29.0%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Oct '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 1,643.40
1,851.18
1,843.60
1,904.20
1,989.34
2,042.33
2,167.42
2,309.08
2,419.93
2,406.60
2,365.37
growth rate 12.6% -0.4% 3.3% 4.5% 2.7% 6.1% 6.5% 4.8% -0.6% -1.7%
Op.Income 449.90
432.97
461.40
450.00
544.08
578.25
628.56
677.97
691.24
716.80
679.61
growth rate -3.8% 6.6% -2.5% 20.9% 6.3% 8.7% 7.9% 2.0% 3.7% -5.2%
IBT 437.90
509.25
487.60
490.10
490.74
541.92
600.11
641.10
682.15
678.24
610.91
growth rate 16.3% -4.3% 0.5% 0.1% 10.4% 10.7% 6.8% 6.4% -0.6% -9.9%
Net Income 381.80
432.97
461.40
450.00
431.62
469.05
521.50
20.31
593.79
592.20
521.57
growth rate 13.4% 6.6% -2.5% -4.1% 8.7% 11.2% -96.1% 2,823.5% -0.3% -11.9%
EPS 4.06
4.69
5.19
5.20
5.07
5.65
6.41
0.25
7.65
8.69
8.36
growth rate 15.5% 10.7% 0.2% -2.5% 11.4% 13.5% -96.1% 2,960.0% 13.6% -3.8%
Gross Profit 990.10
1,120.69
1,161.00
1,120.80
1,164.43
1,199.66
1,275.97
1,362.01
1,427.37
1,395.90
1,358.68
growth rate 13.2% 3.6% -3.5% 3.9% 3.0% 6.4% 6.7% 4.8% -2.2% -2.7%
R&D 84.30
92.35
96.00
100.50
107.73
118.55
125.19
132.59
143.40
142.96
140.78
growth rate 9.6% 4.0% 4.7% 7.2% 10.0% 5.6% 5.9% 8.2% -0.3% -1.5%

Quarterly Statements

Item Name Jan '20 Jun '20 Sep '20 Dec '20 Apr '21
Earnings BIT 86.76
158.45
164.19
270.56
growth rate 82.6% 3.6% 64.8%
Balance Sheet Jan '20 Jun '20 Sep '20 Dec '20 Apr '21
Acct.Receivable 522.21
496.28
494.43
573.32
growth rate -5.0% -0.4% 16.0%
Acct.Payable 61.06
50.33
60.36
72.21
growth rate -17.6% 19.9% 19.6%
Cur.Assets 1,327.78
1,269.43
1,291.67
1,401.03
growth rate -4.4% 1.8% 8.5%
Total Assets 2,666.52
2,648.30
2,679.29
2,839.92
growth rate -0.7% 1.2% 6.0%
Cash 390.06
339.04
374.93
436.70
683.78
growth rate -13.1% 10.6% 16.5% 56.6%
Inventory 344.01
344.01
326.95
304.28
growth rate 0.0% -5.0% -6.9%
Cur.Liabilities 551.05
697.32
722.19
804.98
785.05
growth rate 26.5% 3.6% 11.5% -2.5%
Liabilities 3,004.52
2,840.04
2,720.87
2,607.78
2,980.60
growth rate -5.5% -4.2% -4.2% 14.3%
LT Debt 1,845.98
1,546.16
1,436.53
1,251.51
1,603.09
growth rate -16.2% -7.1% -12.9% 28.1%
Equity -338.00
-191.74
-41.58
232.14
230.96
growth rate 0.0% 0.0% 100.0% -0.5%
Common Shares 61.90
1.61
1.61
1.62
growth rate -97.4% 0.1% 0.2%
Cash Flow Statement Jan '20 Jun '20 Sep '20 Dec '20 Apr '21
Capital Expenditures 51.13
45.90
28.31
47.04
growth rate -10.2% -38.3% 66.2%
Cash Dividends
growth rate
Cash From OA 151.64
198.81
172.58
267.48
growth rate 31.1% -13.2% 55.0%
Sale Purchase of Stock
growth rate
FCF 100.51
152.91
144.27
220.44
growth rate 52.1% -5.7% 52.8%
Income Statement Jan '20 Jun '20 Sep '20 Dec '20 Apr '21
Sales 464.94
519.98
593.78
786.66
608.55
growth rate 11.8% 14.2% 32.5% -22.6%
Op.Income 86.76
158.45
164.19
270.56
growth rate 82.6% 3.6% 64.8%
IBT 57.86
145.36
150.44
257.25
growth rate 151.2% 3.5% 71.0%
Net Income 53.56
122.93
126.77
218.31
growth rate 129.5% 3.1% 72.2%
EPS
growth rate
Gross Profit 254.30
306.85
331.44
466.09
growth rate 20.7% 8.0% 40.6%
R&D 34.99
31.16
34.97
39.66
38.09
growth rate -11.0% 12.3% 13.4% -4.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (32.19)

YOY Growth Grade:

D (45.54)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 300.33 31.35 21.31
EPS / Growth 9.1% 9.88 5.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 5.1% 5.1%
Future PE 2.00 15.79 15.79
Future EPS 10.91 16.31 16.31
Value Price
MOS %
5.40
-98.3%
63.67
-79.4%
63.67
-79.4%
MOS Price 2.70 31.84 31.84
IRT 27.17 18.53 18.53

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.